Clinical Trial Update: Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

View source ↗

Summary

The update presents results from a cerebrospinal fluid biomarker study in participants with Alzheimer's disease, progressive supranuclear palsy, and controls. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Progressive Supranuclear Palsy

Snippet

Sponsor: KineMed | Conditions: Alzheimer Disease, Progressive Supranuclear Palsy | Status: COMPLETED